The latest oncology treatment & supportive care news
Groundbreaking treatment approach shows promise in hard-to-treat cancers
Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing…
The latest oncology treatment & supportive care news
Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing…
Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis…
A 10-minute virtual reality (VR) session significantly lessened pain in hospitalised patients with cancer in…
Testing for tumour DNA in the blood can successfully identify advanced bladder cancer patients who…
A new radiotheranostic system has the ability to detect and treat ovarian cancer noninvasively, according…
RCSI research has found that venetoclax, a medication currently approved for leukaemia, has benefits for…
St. Jude Children’s Research Hospital scientists reversed an aggressive cancer, reverting malignant cells towards a…
Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations…
Welcome to the ninth episode of Supportive Care Matters, a podcast Hosted by Medical Oncologist Professor Bogda Koczwara AM from Adelaide, Australia.
Navigating the silent struggle that many cancer survivors face, this episode promises insights into the lesser-known yet impactful world of chemotherapy-induced peripheral neuropathy (CIPN). With the expertise of Professor David Goldstein and Associate Professor Susanna Park, this episode sheds light on how CIPN disrupts daily life in ways that go unnoticed by the medical community.
In the domain of cancer treatment, the detrimental effects of concurrent chemoradiotherapy (CRT) often lead…